scispace - formally typeset
C

Channing J. Der

Researcher at University of North Carolina at Chapel Hill

Publications -  443
Citations -  64879

Channing J. Der is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: GTPase & Signal transduction. The author has an hindex of 122, co-authored 425 publications receiving 59736 citations. Previous affiliations of Channing J. Der include Wistar Institute & University of Southern California.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.

TL;DR: The current status of the different approaches and targets that are under evaluation and development for the therapeutic intervention of this key signaling pathway in human disease are summarized.
Journal ArticleDOI

GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors

TL;DR: With 69 distinct homologues, Dbl-related GEFs represent the largest family of direct activators of Rho GTPases in humans, and they activate RhoGTPases within particular spatio-temporal contexts.
Journal ArticleDOI

Mitogenic Signaling Mediated by Oxidants in Ras-Transformed Fibroblasts

TL;DR: H-RasV12-induced transformation can lead to the production of ·O2− through one or more pathways involving a flavoprotein and Rac1, suggesting a possible mechanism for the effects of antioxidants against Ras-induced cellular transformation.
Journal ArticleDOI

Drugging the undruggable Ras: mission possible?

TL;DR: This Review summarizes the progress and the promise of five key approaches for the development of RAS-inhibitory molecules and addresses the issue of whether blocking RAS membrane association is a viable approach.